How many email patterns does XyloCor Therapeutics, Inc. use?

XyloCor Therapeutics, Inc. uses 2 known email patterns.

What domain does XyloCor Therapeutics, Inc. use for work emails?

XyloCor Therapeutics, Inc. uses xylocor.com for work email addresses.

Most Common Email Formats at XyloCor Therapeutics, Inc.

XyloCor Therapeutics, Inc.'s most common email format is First.Last@xylocor.com (ex. John.Doe@xylocor.com), used for 97% of xylocor.com addresses. XyloCor Therapeutics, Inc. uses 2 email patterns.

@xylocor.com

2 patterns

Format	Example	Share of xylocor.com
First.Last@xylocor.comMost common	John.Doe@xylocor.com	97%
FirstLast@xylocor.com	JohnDoe@xylocor.com	3%

Need a specific person's email?

Browse XyloCor Therapeutics, Inc.'s employee directory (about 20 employees) and reveal verified emails free.

Frequently Asked Questions

What does XyloCor Therapeutics, Inc. do?

XyloCor Therapeutics, Inc. was founded in 2013 and operates in the Research Services industry, alongside similar companies like Anchiano Therapeutics, UroGen Pharma and Unibio. You can visit xylocor.com. Explore XyloCor Therapeutics, Inc.'s company overview page for more information.

What is XyloCor Therapeutics, Inc.'s email address format?

XyloCor Therapeutics, Inc.'s email format typically follows the pattern of First.Last@xylocor.com; this email format is used 97% of the time. Other contacts within LeadIQ's database had email formats such as FirstLast@xylocor.com. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does XyloCor Therapeutics, Inc. have currently?

XyloCor Therapeutics, Inc. has approximately 20 employees as of October 2026. Key team members to contact include Chief Medical Officer: E. D., Vp, Head Of Technical Operations And Cmc: N. G. and Director Of Finance And Operations: J. A. For more team information and contact data, explore XyloCor Therapeutics, Inc.'s employee directory with LeadIQ.

XyloCor Therapeutics, Inc. Email Format

Research ServicesPennsylvania, United States11-50 Employees

XyloCor Therapeutics, Inc. is a development-stage biotechnology company in the research services industry focused on developing first-in-class gene therapies for cardiovascular disease. The company is based in King of Prussia, Pennsylvania, at 411 Swedeland Road Suite 23-1080. It employs 11-50 people. In its recent history, John Tucker was appointed President and Chief Executive Officer in March 2026, and Rachel Mears joined the Board of Directors in January 2025. The company has pursued financing activities, including a Series B in January 2025 to support its cardiovascular gene therapy programs. The organization maintains a website at https://xylocor.com.

Most common format

First.Last@xylocor.com

Example: John.Doe@xylocor.com

2 patterns. See all formats

Verify a XyloCor Therapeutics, Inc. email address

Free with a LeadIQ account. No credit card.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Most Common Email Formats at XyloCor Therapeutics, Inc.

@xylocor.com

Need a specific person's email?

Frequently Asked Questions

What does XyloCor Therapeutics, Inc. do?

What is XyloCor Therapeutics, Inc.'s email address format?

How many employees does XyloCor Therapeutics, Inc. have currently?

XyloCor Therapeutics, Inc. Email Format

Ready to create more pipeline?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Everything for prospecting,
in one platform.